These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7607576)

  • 21. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
    Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J
    Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.
    Gibcus JH; Kok K; Menkema L; Hermsen MA; Mastik M; Kluin PM; van der Wal JE; Schuuring E
    Hum Genet; 2007 Apr; 121(2):187-201. PubMed ID: 17171571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.
    Freier K; Sticht C; Hofele C; Flechtenmacher C; Stange D; Puccio L; Toedt G; Radlwimmer B; Lichter P; Joos S
    Genes Chromosomes Cancer; 2006 Feb; 45(2):118-25. PubMed ID: 16235239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the EMS1 gene and its product, human Cortactin.
    Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
    Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
    Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
    Lázár V; Ecsedi S; Szöllosi AG; Tóth R; Vízkeleti L; Rákosy Z; Bégány A; Adány R; Balázs M
    Mod Pathol; 2009 Oct; 22(10):1367-78. PubMed ID: 19633643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.
    Janssen JW; Imoto I; Inoue J; Shimada Y; Ueda M; Imamura M; Bartram CR; Inazawa J
    J Hum Genet; 2002; 47(9):460-4. PubMed ID: 12202983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of 11q13 in ovarian carcinoma.
    Brown LA; Kalloger SE; Miller MA; Shih IeM; McKinney SE; Santos JL; Swenerton K; Spellman PT; Gray J; Gilks CB; Huntsman DG
    Genes Chromosomes Cancer; 2008 Jun; 47(6):481-9. PubMed ID: 18314909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1.
    Brookes S; Lammie GA; Schuuring E; de Boer C; Michalides R; Dickson C; Peters G
    Genes Chromosomes Cancer; 1993 Apr; 6(4):222-31. PubMed ID: 7685625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome 11q13 abnormalities in human breast cancer.
    Fantl V; Smith R; Brookes S; Dickson C; Peters G
    Cancer Surv; 1993; 18():77-94. PubMed ID: 8013002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
    Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
    Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products.
    Katoh M; Katoh M
    Int J Oncol; 2003 Jun; 22(6):1375-81. PubMed ID: 12739008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
    Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA amplification at 11q13.5-q14 in human breast cancer.
    Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
    Oncogene; 1992 Dec; 7(12):2513-7. PubMed ID: 1461654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas.
    Tsuruta H; Sakamoto H; Onda M; Terada M
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1529-36. PubMed ID: 8250909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.